Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,344,326
  • Shares Outstanding, K 227,752
  • Annual Sales, $ 1,526 M
  • Annual Income, $ -41,460 K
  • 60-Month Beta 0.31
  • Price/Sales 7.53
  • Price/Cash Flow 19.00
  • Price/Book 4.39
Trade QGEN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.54
  • Number of Estimates 1
  • High Estimate 0.54
  • Low Estimate 0.54
  • Prior Year 0.36
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.42 +0.79%
on 10/23/20
55.27 -9.88%
on 10/12/20
-0.92 (-1.81%)
since 09/23/20
3-Month
46.11 +8.02%
on 08/10/20
55.27 -9.88%
on 10/12/20
+1.25 (+2.57%)
since 07/23/20
52-Week
28.20 +76.63%
on 10/24/19
55.27 -9.88%
on 10/12/20
+21.66 (+76.94%)
since 10/23/19

Most Recent Stories

More News
Align's (ALGN) ClinCheck Suite Now Commercially Available

Align Technology's (ALGN) ClinCheck treatment-planning software's commercial availability is expected to boost doctor performances due to ready availability of treatment plans.

QGEN : 49.81 (-1.33%)
BSX : 37.17 (+0.84%)
ALGN : 469.56 (+3.60%)
TMO : 480.17 (-0.38%)
Intersect ENT (XENT) Posts Preliminary Q3 Data, Dull Q4 View

Intersect ENT (XENT) expects the strength in its product lines to have substantially boosted revenues in the third quarter.

QGEN : 49.81 (-1.33%)
BSX : 37.17 (+0.84%)
TMO : 480.17 (-0.38%)
XENT : 16.12 (+0.62%)
The Zacks Analyst Blog Highlights: Edwards Lifesciences, QIAGEN, IDEXX, LHC and ResMed

The Zacks Analyst Blog Highlights: Edwards Lifesciences, QIAGEN, IDEXX, LHC and ResMed

EW : 80.41 (+1.30%)
RMD : 183.03 (+0.11%)
QGEN : 49.81 (-1.33%)
LHCG : 216.91 (-1.00%)
IDXX : 429.66 (+1.43%)
3 MedTech Growth Stocks to Scoop Up Ahead of Q3 Earnings

Here are three growth stocks from the MedTech space that investors can pick ahead of the quarterly releases.

EW : 80.41 (+1.30%)
RMD : 183.03 (+0.11%)
QGEN : 49.81 (-1.33%)
LHCG : 216.91 (-1.00%)
IDXX : 429.66 (+1.43%)
AnaptysBio (ANAB) Jumps: Stock Rises 7.7%

AnaptysBio (ANAB) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

QGEN : 49.81 (-1.33%)
ANAB : 25.73 (-0.73%)
IVERIC bio (ISEE) Catches Eye: Stock Jumps 6.8%

IVERIC bio (ISEE) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

QGEN : 49.81 (-1.33%)
ISEE : 6.00 (-0.08%)
NeoGenomics (NEO) Looks Good: Stock Adds 5.5% in Session

NeoGenomics (NEO) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

QGEN : 49.81 (-1.33%)
NEO : 41.34 (-2.64%)
Uptrend Call Working As Qiagen Nv Stock Rises 27.1% (QGEN)

SmarTrend identified an Uptrend for Qiagen Nv (NYSE:QGEN) on March 3rd, 2020 at $41.29. In approximately 8 months, Qiagen Nv has returned 27.12% as of today's recent price of $52.48.

QGEN : 49.81 (-1.33%)
Boston Scientific Gets a Boost From MedSurg Arm Amid Coronavirus

Within Endoscopy, Boston Scientific (BSX) believes that business recovery started since June.

QGEN : 49.81 (-1.33%)
ABT : 107.79 (-1.54%)
BSX : 37.17 (+0.84%)
TMO : 480.17 (-0.38%)
Passage Bio (PASG) Looks Good: Stock Adds 5.4% in Session

Passage Bio (PASG) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

QGEN : 49.81 (-1.33%)
PASG : 17.06 (-0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

See More

Key Turning Points

2nd Resistance Point 50.42
1st Resistance Point 50.11
Last Price 49.81
1st Support Level 49.46
2nd Support Level 49.12

See More

52-Week High 55.27
Last Price 49.81
Fibonacci 61.8% 44.93
Fibonacci 50% 41.74
Fibonacci 38.2% 38.54
52-Week Low 28.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar